Atara Biotherapeutics, INC. (ATRA) — DEF 14A Filings
All DEF 14A filings from Atara Biotherapeutics, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Atara Biotherapeutics Executive Compensation Details
— Apr 28, 2025 Risk: low
Atara Biotherapeutics, Inc. filed its DEF 14A on April 28, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing inclu -
Atara Biotherapeutics Files DEF 14A for Annual Meeting
— Apr 26, 2024 Risk: low
Atara Biotherapeutics, Inc. (ATRA) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. Atara Biotherapeutics, Inc. filed a DEF 14A form on April 2
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX